Celestial Biolabs (Delisted) share news and announcements

BSE: 532871Pharmaceuticals & Biotechnology

Formerly Celestial Labs

Last traded ₹1.75 on 11 Mar 2020

Delisted on 16 Oct 2024.

Celestial Biolabs share news and announcements

634 announcements, routine notices left out, newest first. Page 7 of 13.

Sep 2017
- 13 Sep · Results
  Financial results for the period ended 30-Jun-2017. (opens in a new tab)
- 7 Sep · Board meeting
  To consider and take on record the Un-audited financial results of the Company for the quarter / 3 months ended June 30, 2017 (opens in a new tab)
- 7 Sep · Results
  This is to intimate you that a meeting of the Board of Directors and Audit Committee .... (opens in a new tab)
Jul 2017
- 21 Jul
  Statement Of Investor Complaints For The Quarter Ended June 30, 2017 (opens in a new tab)
- 21 Jul · Shareholding for the Period Ended June 30, 2017
  Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....
Jun 2017
May 2017
- 30 May · Results
  Financial Results Updates (opens in a new tab)
- 30 May · Board meeting
  This is to inform you that the Board of Directors in their just concluded Board meeting held today have considered and adopted the audited financial results of the Company for the quarter/year .... (opens in a new tab)
- 30 May · Results
  Financial results for the period ended 31-Mar-2017. (opens in a new tab)
- 22 May · Board meeting
  To consider and take on record the audited financial results of the Company for the quarter / year ended March 31, 2017. (opens in a new tab)
- 22 May · Board Meeting To Be Held On 30Th May 2017
  This is to intimate that a meeting of the Board of Directors and Audit Committee .... (opens in a new tab)
Apr 2017
- 26 Apr · Compliance Certificate For The Period Ended March 31, 2017
  Please find enclosed the certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year .... (opens in a new tab)
- 25 Apr · CERTIFICATE UNDER REGULATION 40 (9) OF SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENTS) REGULATIONS, 2015
  We are enclosing the certificate received from the practicing company secretary .... (opens in a new tab)
- 17 Apr · Shareholding for the Period Ended March 31, 2017
  Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
- 17 Apr · Statement Of Investor Complaints For The Quarter Ended 31St March, 2017
  We are furnishing herewith a statement of Investor complaints for the quarter ended 31.03.2017 The number of investor complaints pending at the beginning of the quarter 0 Received during the quarter 0 Disposed of during the quarter 0 Unresolved at the end of the quarter 0 (opens in a new tab)
- 12 Apr · Disclosure
  Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 7 Apr · Disclosure
  Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Feb 2017
Jan 2017
- 19 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) .... (opens in a new tab)
- 17 Jan · Shareholding for the Period Ended December 31, 2016
  Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
- 2 Jan · Meeting
  Proceedings of the Annual General Meeting of the Company held on December 30, 2016. (opens in a new tab)
- 2 Jan · Meeting
  Voting results of the Annual General Meeting of the company held on December 30, 2016 . (opens in a new tab)
Dec 2016
- 31 Dec · Meeting
  Proceedings of 18th Annual General Meeting (AGM) of the Company held on December 30, 2016. (opens in a new tab)
- 31 Dec · Results
  Details of Voting results at the Annual General Meeting (AGM) of the Company held on December 30, 2016, under Regulation 44(3) of SEBI .... (opens in a new tab)
- 9 Dec · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from December 28, 2016 to December 30, 2016 (both days inclusive) ....
- 9 Dec · Meeting
  Register of Members and Share Transfer Books of the Company shall remain closed from December 28, 2016 to December 30, 2016 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on December 30, 2016. (opens in a new tab)
- 3 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padma Singh (opens in a new tab)
- 3 Dec · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Celestial Biolabs Ltd (opens in a new tab)
- 2 Dec · Legal
  Exchange had sought clarification from Celestial Biolabs Limited with respect to announcement dated 30-Nov-2016, informing that the Board of Directors in their Board meeting held on November 30, 2016, have transacted the following business : (1) Allotted 21,00,000 equity shares of Rs.10/- each, upon conversion of 21,00,000 convertible warrants, on preferential basis to promoter & non promoter group in accordance with the SEBI Guidelines; (2) To issue 55,94,600 convertible warrants on preferential basis to promoters & non-promoter group, subject to approval from shareholders, stock exchanges or any statutory body as may be required in this regard. On basis of above the Company is required to clarify following: 1. Names of the investors; The response of the Company is attached. (opens in a new tab)
- 1 Dec · Legal
  Exchange has sought clarification from Celestial Biolabs Limited with respect to announcement dated 30-Nov-2016, informing that the Board of Directors in their Board meeting held on November 30, 2016, have transacted the following business : (1) Allotted 21,00,000 equity shares of Rs.10/- each, upon conversion of 21,00,000 convertible warrants, on preferential basis to promoter & non promoter group in accordance with the SEBI Guidelines; (2) To issue 55,94,600 convertible warrants on preferential basis to promoters & non-promoter group, subject to approval from shareholders, stock exchanges or any statutory body as may be required in this regard.On basis of above the Company is required to clarify following:1. Names of the investors;The response of the Company is awaited.
Nov 2016
Oct 2016
- 22 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) .... (opens in a new tab)
- 19 Oct · Shareholding for the Period Ended September 30, 2016
  Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
- 4 Oct · Extension of Time for Convening the A G M
  In accordance with the provisions of Section 96(1) of the Companies Act, 2013 the Company have obtained extension of time for convening the AGM .... (opens in a new tab)
- 4 Oct · Meeting
  In accordance with the provisions of Section 96(1) of the Companies Act, 2013 we have obtained extension of time for convening the Annual General Meeting for the financial year 2015-16 upto 3 months (i.e.,upto December 31, 2016 ) from the Registrar of Companies, Ministry of Corporate Affairs vide their letter dated September 30, 2016. (opens in a new tab)
Aug 2016

Celestial Biolabs share news and announcements

Sep 2017

Jul 2017

Jun 2017

May 2017

Apr 2017

Feb 2017

Jan 2017

Dec 2016

Nov 2016

Oct 2016

Aug 2016